View Item 

Show simple item record

Methylglyoxal bis-guanylhydrazone in advanced bladder cancer
dc.contributor.authorVon Hoff, Daniel D.en_US
dc.contributor.authorBlumenstein, Brent A.en_US
dc.contributor.authorPollock, Theodore W.en_US
dc.contributor.authorDavid Crawford, E.en_US
dc.contributor.authorWeick, James K.en_US
dc.contributor.authorGuy, Jerry T.en_US
dc.contributor.authorEisenberger, Mario A.en_US
dc.contributor.authorFletcher, William S.en_US
dc.contributor.authorNatale, Ronald B.en_US
dc.date.accessioned2006-04-10T13:58:03Z
dc.date.available2006-04-10T13:58:03Z
dc.date.issued1990en_US
dc.identifier.citationVon Hoff, Daniel D., Blumenstein, Brent A., Pollock, Theodore W., David Crawford, E., Weick, James K., Guy, Jerry T., Eisenberger, Mario, Fletcher, William S., Natale, Ronald B. (1990)."Methylglyoxal bis-guanylhydrazone in advanced bladder cancer." European Journal of Cancer and Clinical Oncology 26(7): 848-848. <http://hdl.handle.net/2027.42/28924>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B7GGR-4C1X45G-4M/2/6fd219a444075f232e105c62abc99883en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/28924
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2145912&dopt=citationen_US
dc.format.extent136603 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleMethylglyoxal bis-guanylhydrazone in advanced bladder canceren_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelOtolaryngologyen_US
dc.subject.hlbsecondlevelOphthalmologyen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbsecondlevelObstetrics and Gynecologyen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan Medical Center, Ann Arbor, Michigan, U.S.A.en_US
dc.contributor.affiliationotherUniversity of Texas Health Science Center at San Antonio, San Antonio, Texas, U.S.A.en_US
dc.contributor.affiliationotherSouthwest Oncology Group Statistical Center, Seattle, Washington, U.S.A.en_US
dc.contributor.affiliationotherColumbus CCOP, Columbus, Ohio, U.S.A.en_US
dc.contributor.affiliationotherUniversity of Colorado, Denver, Colorado, U.S.A.en_US
dc.contributor.affiliationotherCleveland Clinic Foundation, Cleveland, Ohio, U.S.A.en_US
dc.contributor.affiliationotherColumbus CCOP, Columbus, Ohio, U.S.A.en_US
dc.contributor.affiliationotherUniversity of Maryland UCOP, Baltimore, Maryland, U.S.A.en_US
dc.contributor.affiliationotherOregon Health Sciences University, Portland, Oregon, U.S.A.en_US
dc.identifier.pmid2145912en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/28924/1/0000761.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0277-5379(90)90171-Oen_US
dc.identifier.sourceEuropean Journal of Cancer and Clinical Oncologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
0000761.pdf
Size:
133.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.